Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) shares reached a new 52-week low on Tuesday . The stock traded as low as C$0.11 and last traded at C$0.11, with a volume of 154925 shares. The stock had previously closed at C$0.12.
Nanalysis Scientific Stock Performance
The stock has a fifty day simple moving average of C$0.13 and a two-hundred day simple moving average of C$0.13. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.10 and a current ratio of 1.42. The stock has a market capitalization of C$16.03 million, a price-to-earnings ratio of -3.83 and a beta of -0.56.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Further Reading
- Five stocks we like better than Nanalysis Scientific
- Can Marvell Keep Up in the Custom AI Chip Race?
- DraftKings Falls 7.6%: Is Kalshi’s NFL Lead Really That Big?
- Gaming Your Portfolio: Should You Add Take-Two Ahead of GTA 6’s November Launch?
- Chips to Bots: Qualcomm’s Agentic AI Breakout
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
